RxDoctor Payments Data

Leslie Verucci, NP

Adult Health · Newark, DENPI 1275531873

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 90.2% of the total across 28 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 18 manufacturers, the largest accounting for just 12.8% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2023 at $1,365 and has fallen 81.8% since, to $249 in 2025. Among adult health clinicians in DE with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$2,503in general payments, 2019–2025

Across 28 payments — averaging $89.39 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Johnson & Johnson$320
  • AstraZeneca$308
  • GSK$210
  • Lilly USA, LLC$210
  • E.r. Squibb & Sons, L.L.C.$160
  • Rigel Pharmaceuticals, Inc.$125
  • plus $1K from 12 others

What the payments were for

  • Food & beverage$2,25790%
  • Education$24610%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,503 in reported general payments places this provider in the 90th percentile of 65 adult health providers in Delaware.

See all adult health providers in Delaware

Medicare billing

Part B allowed, 2024
$39,479
Medicare patients
415
Services billed
632

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav41$470
Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst31$329
Fluticasone Propionate23$290
Cephalexin41$235
Methylprednisolone19$199
Azithromycin23$165
Doxycycline Hyclate22$160
Polymyxin B Sul-TrimethoprimPolymyxin B Sulf/Trimethoprim15$149
Ondansetron OdtOndansetron11$142
Clindamycin Hcl13$133
Cyclobenzaprine Hcl17$118
Amoxicillin26$105
Ofloxacin11$95
Prednisone21$37
Ibuprofen11$35

Paid to pharmacies, not to this prescriber.

Other adult health in Newark

See the full list for Delaware

Where these figures come from

Is this you, or does something look wrong? →